P164 Value of fatigue: patients vs. physicians – time trade-off approach. (23rd March 2020)

• Record Type: Journal Article
• Authors: Düsing, Christina; Schneider, Matthias; Chehab, Gamal
• Is Part Of: Lupus science & medicine. Volume 7(2020)Supplement 1
• Page Start: A110
• Page End: A110
• Publication Date: 2020-03-23
• Subjects: Systemic lupus erythematosus -- Periodicals; 616.772005
• DOI: 10.1136/lupus-2020-eurolupus.206
• Languages: English
• ISSNs: 2398-8851

Abstract

Abstract : Introduction: Fatigue is a common symptom in SLE patients and often held responsible for their reduced quality of life. With this survey, we wanted to examine the degree of suffering in SLE patients with fatigue and determine, whether they would trade in years in order to live without fatigue or if they would trade in fatigue for other disease manifestations (skin, joints or kidney). Methods: Our survey took place during a meeting with patients from the German SLE self-help community on World Lupus Day, May 10th 2019 in Duesseldorf/Germany. Using Edivote®, an anonymous audience response system, we asked patients: if they had been questioned by their treating physicians about fatigue (1:always, 2:sometimes, 3:never), how many years of life they would sacrifice in order to live without fatigue (0, 5, 10, 15, >15 years, respectively) and if they would trade in fatigue for another disease manifestation (skin, joints or kidney). Results: 26 patients (96.2% female) took part in our survey. Most patients were ≤50 years old (61.5%) with a disease duration of >5 years (81.0%). Six patients were regularly asked about fatigue, four patients were sometimes asked and eight patients had never been asked about fatigue. The results from the time trade-off question are shown in figure 1 . Five patients were willing to trade in fatigue for a skin manifestation (consistent redness on exposed skin); one patient wanted to trade in fatigue for a kidney manifestation (50% reduction of kidney function, edema and fluid restriction). Conclusion: In our cohort, 42% of responding patients had never been asked about fatigue. To our surprise, almost all patients were willing to trade in ≥5 years for a life without fatigue. This result underlines patients' degree of suffering and should raise more awareness for SLE patients living with fatigue. Our results clearly indicate the discordant assessment of the importance of fatigue by patients and physicians. These findings with respect to time trade-off should be validated in a larger cohort.